Literature DB >> 19264831

Dosimetric characterisation of bismuth shields in CT: measurements and Monte Carlo simulations.

Sangroh Kim1, Terry T Yoshizumi, Donald P Frush, Colin Anderson-Evans, Greta Toncheva.   

Abstract

Although bismuth shields are frequently used in radiology to reduce radiation dose, its mechanism has not been fully investigated. Dosimetric characteristics of bismuth shields in computed tomography (CT) were assessed with ion chamber and Monte Carlo (MC) simulations. Primary attenuation and backscatter effects of paediatric (2-ply) and adult (4-ply) bismuth shields were measured. Simulated CT beams were used for ion chamber measurements. Radiation doses were measured free-in-air and in the tissue-equivalent slabs. MC simulations for the same settings were also performed. Mean dose reductions from primary attenuation were 23% (2-ply) and 40% (4-ply). The dose increase from backscatter was 2% for both shields. MC simulations for primary beam dose reduction were 20% (2-ply) and 38% (4-ply); the backscatter dose increase was around 6% for both shields. In summary, primary attenuation is the major factor that introduces the dose reduction in bismuth and the dose increase from backscatter is negligible.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264831     DOI: 10.1093/rpd/ncp025

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  3 in total

1.  Bismuth shielding in CT: support for use in children.

Authors:  Sangroh Kim; Donald P Frush; Terry T Yoshizumi
Journal:  Pediatr Radiol       Date:  2010-08-24

2.  Eye-lens bismuth shielding in paediatric head CT: artefact evaluation and reduction.

Authors:  Maria Raissaki; Kostas Perisinakis; John Damilakis; Nicholas Gourtsoyiannis
Journal:  Pediatr Radiol       Date:  2010-06-16

3.  Generation of the additional fluorescence radiation in the elastomeric shields used in computer tomography (CT).

Authors:  P Szajerski; M Zaborski; H Bem; W Baryn; E Kusiak
Journal:  J Radioanal Nucl Chem       Date:  2013-05-31       Impact factor: 1.371

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.